Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma

Gut

Volumn 43, Issue 2, 1998, Pages 216-222

  Van Sandick, J W ^a   Van Lanschot, J J B ^a   Kuiken, B W ^a   Tytgat, G N J ^a   Offerhaus, G J A ^a   Obertop, H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Barrett's oesophagus; Endoscopic surveillance; Oesophageal adenocarcinoma

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENDOSCOPIC BIOPSY; ESOPHAGOSCOPY; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031855413     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.2.216     Document Type: Article

References (47)

1. Winters C, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118-24.
2. Stein HJ, Barlow AP, DeMeester TR, et al. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 1992;216:35-43.
3. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
4. Spechler SJ, Robbins AH, Rubins HB, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984;87:927-33.
5. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
6. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
7. Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-80.
8. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362-71.
9. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14: 931-68.
10. Hamilton SR. Adenocarcinoma in Barrett's oesophagus. In: Whitehead R, ed. Gastrointestinal and oesophageal pathology. Edinburgh: Churchill Livingstone, 1989;683-700.
11. Pera M, Trastek VF, Carpenter HA, et al. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 1992;54:199-204.
12. Rice TW, Falk GW, Achkar E, et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88:1832-6.
13. Edwards MJ, Gable DR, Lentsch AB, et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996;223:585-91.
14. Stein HJ. Esophageal cancer: screening and surveillance. Results of a consensus conference held at the VIth world congress of the International Society for Diseases of the Esophagus. Diseases of the Esophagus 1996;9:S3-19.
15. UICC, International Union Against Cancer. TNM Atlas: illustrated guide to the TNM/pTNM classification of malignant tumours, 3rd edition, 2nd revision. Berlin, Heidelberg, New York: Springer-Verlag, 1992.
16. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
17. Hameeteman W, Tytgat GNJ, Houthoff HJ, et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
18. Williamson WA, Ellis FH Jr, Gibb SP, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151:2212-6.
19. Iftikhar SY, James PD, Steele RJC, et al. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992;33:1155-8.
20. Streitz JM Jr, Ellis FH Jr, Gibb SP, et al. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg 1991;213:122-5.
21. DeMeester TR, Attwood SEA, Smyrk TC, et al. Surgical therapy in Barrett's esophagus. Ann Surg 1990;212:528-40.
22. Menke-Pluymers MBE, Schoute NW, Mulder AH, et al. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 1992;33:1454-8.
23. Lerut T, Coosemans W, Van Raemdonck D, et al. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg 1994;107:1059-65.
24. Lederle FA. Endoscopic surveillance of patients with Barrett esophagus. Ann Intern Med 1987;107:592-3.
25. Van Der Burgh A, Dees J, Hop WCJ, et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996;39:5-8.
26. Wright TA, Gray MR, Morris AI, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996;39:574-9.
27. Streitz JM, Ellis FH, Tilden RL, et al. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with screening mammography [abstract]. Am J Gastroenterol 1996;91:A71.
28. Sonnenberg A, El-Serag HB. Cost-effectiveness of endoscopic screening [abstract]. Gastroenterology 1997;112: A660.
29. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr. Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993;105:383-7.
30. Peters JH, Clark GWB, Ireland AP, et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994;108:813-21.
31. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst 1980;64:1263-72.
32. Axon ATR, Boyle P, Riddell RH, et al. Summary of a working party on the surveillance of premalignant lesions. Am J Gastroenterol 1994;89:S160-8.
33. Hutchison GB, Shapiro S. Lead time gained by diagnostic screening for breast cancer. J Natl Cancer Inst 1968;41: 665-81.
34. Zelen M. Theory of early detection of breast cancer in the general population. In: Henson JC, Mattheiem WH, Rozencweig M, eds. Breast cancer: trends in research and treatment. New York: Raven Press, 1976;287-300.
35. McArdle JE, Lewin KJ, Randall G, et al. Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol 1992;23:479-82.
36. Tytgat GNJ, Hameeteman W, Onstenk R, et al. The spectrum of columnar-lined esophagus Barrett's esophagus. Endoscopy 1989;21:177-85.
37. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991;32:1441-6.
38. Reid BJ, Blount PL, Rubin CE, et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102:1212-19.
39. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
40. Polkowski W, Van Lanschot JJB, Ten Kate FJW, et al. The value of p53 and Ki67 as markers for tumour progression in the Barren's dysplasia carcinoma sequence. Surg Oncol 1995;4:163-71.
41. Flejou JF, Volant A, Diebold MD, et al. Surexpression de la proteine p53 et endobrachyoesophage. Un evenement frequent et precoce au cours de la carcinogenese. Gastroenterol Clin Biol 1995;19:475-81.
42. Altorki NK, Sunagawa M, Little AG, et al. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991;161:97-9.
43. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996;224:66-71.
44. Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988;94:81-90.
45. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50.
46. Rusch VW, Levine DS, Haggitt R, et al. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer 1994;74:1225-9.
47. Rice TW, Falk GW, Goldblum JR, et al. Superficial adenocarcinoma of the esophagus [abstract]. Gastroenterology 1997;112:A644.